Bio-Techne Ownership | Who Owns Bio-Techne?


OverviewForecastRevenueFinancialsChartTranscripts

Bio-Techne Ownership Summary


Bio-Techne is owned by 100.64% institutional investors, 1.09% insiders. Vanguard group is the largest institutional shareholder, holding 11.73% of TECH shares. T. Rowe Price New Horizons is the top mutual fund, with 3.62% of its assets in Bio-Techne shares.

TECH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBio-Techne100.64%1.09%-1.73%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group18.59M11.73%$1.34B
Blackrock14.99M9.53%$1.07B
Blackrock funding, inc. /de12.17M7.73%$626.21M
Price t rowe associates inc /md/10.65M6.72%$767.43M
State street6.30M4.01%$451.46M
Ameriprise financial4.70M2.97%$338.76M
Morgan stanley4.41M2.80%$316.03M
Geode capital management4.00M2.52%$287.49M
Invesco3.82M2.41%$275.19M
Neuberger berman group3.58M2.26%$258.00M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Broadcrest asset management125.00K11.74%$6.43M
Palo ds manager290.96K6.61%$14.97M
Rgm capital2.20M4.58%$113.19M
Montanaro asset management294.95K3.91%$15.18M
Summit creek advisors250.49K2.46%$17.95M
Brown capital management1.57M2.35%$80.96M
Ownership capital b.v.721.84K2.16%$37.14M
Pembroke management339.79K2.11%$17.48M
American capital management951.61K2.03%$48.96M
Eversept partners, lp394.14K1.87%$20.28M

Top Buyers

HolderShares% AssetsChange
Norges bank1.91M0.02%1.91M
T. rowe price investment management1.24M0.04%1.24M
Price t rowe associates inc /md/10.65M0.09%1.23M
Rgm capital2.20M4.58%1.19M
Capital research global investors1.01M0.01%1.01M

Top Sellers

HolderShares% AssetsChange
Blackrock14.99M0.02%-2.76M
Select equity group2.92M0.63%-2.45M
Blackrock funding, inc. /de12.17M0.01%-1.58M
Massachusetts financial services co /ma/1.66M0.03%-1.37M
Alyeska investment group---911.53K

New Positions

HolderShares% AssetsChangeValue
Norges bank1.91M0.02%1.91M$137.30M
T. rowe price investment management1.24M0.04%1.24M$63.70M
Capital research global investors1.01M0.01%1.01M$51.76M
Qube research518.15K0.03%518.15K$26.66M
Arvin capital management lp170.21K1.79%170.21K$8.76M

Sold Out

HolderChange
Tfo-tdc-1.00
Bartlett & co. wealth management-2.00
Scarborough advisors-2.00
Tfc financial management-2.00
Colonial trust advisors-3.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025555-3.31%158,385,865-1.06%1000.97%2945.38%195-5.80%
Mar 31, 2025571-0.52%160,263,9532.30%1011.04%279-4.12%2055.67%
Dec 31, 2024375-33.86%87,681,274-42.64%550.59%184-25.51%124-41.23%
Sep 30, 2024563-2.09%152,780,329-2.07%960.98%246-11.83%2090.48%
Jun 30, 20245681.25%155,969,245-0.67%991.00%2761.47%20611.96%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
T. Rowe Price New Horizons5.67M3.62%-28.23K
US Small-Cap Growth II Equity Comp5.67M3.62%-1.24M
Vanguard US Total Market Shares ETF5.05M3.20%70.72K
Vanguard Total Stock Mkt Idx Inv4.93M3.18%-104.73K
Vanguard Institutional 500 Index Trust4.49M2.87%28.47K
Vanguard 500 Index Investor3.88M2.50%-568.35K
Vanguard Small Cap Index3.81M2.46%-25.48K
Eaton Vance Atlanta Capital SMID-Cap I3.45M2.20%442.87K
Invesco S&P 500® Equal Weight ETF2.74M1.75%759.00
Champlain Mid Cap Fund, LLC2.55M1.63%-86.39K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 25, 2025Nusse Roeland-Sell$960.39K
Aug 25, 2025BAUMGARTNER ROBERT V-Sell$957.82K
Jun 09, 2025Herr Amy E.-Sell$63.70K
Feb 14, 2025Herr Amy E.-Sell$122.69K
Jan 27, 2025Kelderman Kim Chief Executive OfficerSell$905.53K

Insider Transactions Trends


DateBuySell
2025 Q3-2
2025 Q2-1
2025 Q1-3
2024 Q4--
2024 Q3-1

TECH Ownership FAQ


Who Owns Bio-Techne?

Bio-Techne shareholders are primarily institutional investors at 100.64%, followed by 1.09% insiders and -1.73% retail investors. The average institutional ownership in Bio-Techne's industry, Biotech Stocks , is 306.59%, which Bio-Techne falls below.

Who owns the most shares of Bio-Techne?

Bio-Techne’s largest shareholders are Vanguard group (18.59M shares, 11.73%), Blackrock (14.99M shares, 9.53%), and Blackrock funding, inc. /de (12.17M shares, 7.73%). Together, they hold 28.99% of Bio-Techne’s total shares outstanding.

Does Blackrock own Bio-Techne?

Yes, BlackRock owns 9.53% of Bio-Techne, totaling 14.99M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 1.07B$. In the last quarter, BlackRock decreased its holdings by -2.758M shares, a -15.54% change.

Who is Bio-Techne’s biggest shareholder by percentage of total assets invested?

Broadcrest asset management is Bio-Techne’s biggest shareholder by percentage of total assets invested, with 11.74% of its assets in 125K Bio-Techne shares, valued at 6.43M$.

Who is the top mutual fund holder of Bio-Techne shares?

T. Rowe Price New Horizons is the top mutual fund holder of Bio-Techne shares, with 3.62% of its total shares outstanding invested in 5.67M Bio-Techne shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools